You cannot log in without being assigned a valid TSI role.
Johnson & Johnson is hosting the 11th Kilmer Conference, June 13-16, in Athens Greece for invited professionals in microbiological quality, assurance of sterility and infection control from industry, academia, regulatory authorities and healthcare delivery organizations. The Sterility Assurance Community uses the forum to communicate innovations across medical devices / pharmaceuticals and between industry. The faster pace of product innovation and development means that methods for assuring microbiological quality must evolve quickly using new ways of working that incorporate greater agility, like using the BioTrak® Real-Time Viable Particle Counter (a biofluorescent particle counter).
Invited speakers representing the Modern Microbial Methods working group, Mike Dingle, TSI Sr. Product Specialist, and Petra Merker, Bayer Biological Quality Control Expert, will be presenting: Moving Forward with Bio-Fluorescent Particle Counting Technology.
Starting in 1976, Johnson & Johnson has hosted a total of ten Kilmer Conferences between 1976-2019 for invited professionals in microbiological quality, assurance of sterility and infection control from industry, academia, regulatory authorities and healthcare delivery organizations. Previous conferences focused on advancements in terminal sterilization and aseptic processing, new validation methods, new technologies, and world health issues. Concepts and technical research first presented at previous Kilmer Conferences has helped shape the standards for assurance of sterility, and previous conference content is referenced in the standards used today.
The Kilmer Conference is a memorial conference to celebrate the contributions of Fred Kilmer — a pioneer in infection prevention and a pivotal leader in the pharmaceutical industry. He was the Director of the Scientific Laboratory at Johnson & Johnson from 1889-1934.